Abiomed
(NASDAQ:ABMD)
$377.44
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$377.44
PreMarket: 4:57PM EDT
Day Range- - -52 Wk Range219.85 - 381.99Open / Close- / -Float / Outstanding34.9M / 45.1M
Vol / Avg.- / 871.1KMkt Cap17BP/E64.7450d Avg. Price307.72
Div / Yield-Payout Ratio-Total Float34.9MEPS2.34

Abiomed Stock (NASDAQ:ABMD), Quotes and News Summary

Abiomed Stock (NASDAQ: ABMD) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range219.85 - 381.99Open / Close- / -Float / Outstanding34.9M / 45.1M
Vol / Avg.- / 871.1KMkt Cap17BP/E64.7450d Avg. Price307.72
Div / Yield-Payout Ratio-Total Float34.9MEPS2.34
InvestorPlace - Nov 8, 2022, 3:31PM
Seeking Alpha - Nov 7, 2022, 3:53AM
InvestorsObserver - Nov 1, 2022, 10:41AM
InvestorPlace - Nov 1, 2022, 10:28AM
InvestorPlace - Nov 1, 2022, 9:56AM
Seeking Alpha - Nov 1, 2022, 9:47AM
InvestorPlace - Nov 1, 2022, 9:42AM
TipRanks - Nov 1, 2022, 8:45AM
TipRanks - Nov 1, 2022, 8:15AM
Seeking Alpha - Oct 18, 2022, 3:36AM
Seeking Alpha - Oct 17, 2022, 12:21PM
TipRanks - Aug 5, 2022, 12:16PM
Sector: Health Care.Industry: Health Care Equipment & Supplies
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-02
REV
Q2 2023Est.ActualSurprise
EPS1.0401.300 0.2600
REV273.530M265.921M-7.609M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Abiomed (ABMD) stock?

A

You can purchase shares of Abiomed (NASDAQ: ABMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Abiomed's (ABMD) competitors?

Q

What is the target price for Abiomed (ABMD) stock?

A

The latest price target for Abiomed (NASDAQ: ABMD) was reported by Morgan Stanley on Wednesday, November 2, 2022. The analyst firm set a price target for 380.00 expecting ABMD to rise to within 12 months (a possible 0.68% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Abiomed (ABMD)?

A

The stock price for Abiomed (NASDAQ: ABMD) is $377.44 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Abiomed (ABMD) pay a dividend?

A

There are no upcoming dividends for Abiomed.

Q

When is Abiomed (NASDAQ:ABMD) reporting earnings?

A

Abiomed’s Q3 earnings are confirmed for Thursday, February 2, 2023.

Q

Is Abiomed (ABMD) going to split?

A

There is no upcoming split for Abiomed.

Q

What sector and industry does Abiomed (ABMD) operate in?

A

Abiomed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.